WallStreetZenWallStreetZen

NASDAQ: ONCY
Oncolytics Biotech Inc Earnings & Revenue

ONCY earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$24.0M
Current Profit Margin
0%

ONCY Return on Equity

Current Company
-125%
Current Industry
15.6%
Current Market
-9.5%
ONCY's Return on Equity (-125%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ONCY announces earnings.

ONCY Return on Assets

Current Company
-85.9%
Current Industry
2.2%
ONCY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ONCY Return on Capital Employed

Current Company
-89.4%
Current Industry
17.7%
ONCY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ONCY vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ONCY$0.00-$23.25M-$23.62MN/AN/A
MIRO$958.03k-$26.21M-$27.41M+387.76%N/A
PYXS$0.00-$92.12M-$94.29MN/AN/A
ATOS$0.00-$29.82M-$29.83MN/AN/A
RVPH$0.00-$37.60M-$37.65MN/AN/A

Oncolytics Biotech Earnings & Revenue FAQ

What were ONCY's earnings last quarter?

On Invalid Date, Oncolytics Biotech (NASDAQ: ONCY) reported Q3 2023 earnings per share (EPS) of -$0.10, up 70.49% year over year. Total Oncolytics Biotech earnings for the quarter were -$7.35 million. In the same quarter last year, Oncolytics Biotech's earnings per share (EPS) was -$0.06.

If you're new to stock investing, here's how to buy Oncolytics Biotech stock.

What was ONCY's earnings growth in the past year?

As of Q4 2023, Oncolytics Biotech's earnings has grown year over year. Oncolytics Biotech's earnings in the past year totalled -$23.62 million.

What was ONCY's revenue last quarter?

On Invalid Date, Oncolytics Biotech (NASDAQ: ONCY) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Oncolytics Biotech's revenue was $0.00.

What was ONCY's revenue growth in the past year?

As of Q4 2023, Oncolytics Biotech's revenue has grown null year over year. Oncolytics Biotech's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.